Solid forms of N- (4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trif luoromethyl)phenyl)-4-oxo-5-(trifluoromethyl) -1,4-dihydroquinoline-3-carboxamide

Details for Australian Patent Application No. 2010310617 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Zhang, Beili; Krawiec, Mariusz; Luisi, Brian; Medek, Ales

Agent Cullens

Pub. Number AU-A-2010310617

PCT Pub. Number WO2011/050220

Priority 61/254,614 23.10.09 US

Filing date 21 October 2010

Wipo publication date 28 April 2011

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/050220 Priority application(s): WO2011/050220

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310622-A direct mounted photovoltaic device with improved adhesion and method thereof

2010310612-Process for preparing modulators of cystic fibrosis transmembrane conductance regulator